๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Ursodeoxycholic acid (UDCA) in chronic active hepatitis. Results of a controlled trial

โœ Scribed by Buzzelli, G.; Moscarella, S.; Focardi, G.; Giusti, A.; Gentilini, P.


Book ID
122581826
Publisher
Elsevier Science
Year
1991
Tongue
English
Weight
68 KB
Volume
13
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Effects of ursodeoxycholic acid (UDCA) o
โœ E. Rolandi; R. Franceschini; A. Cataldi; V. Cicchetti; L. Carati; T. Barreca ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Springer ๐ŸŒ English โš– 347 KB

The effects of ursodeoxycholic acid (UDCA, 450 mg daily) in patients with histologically proven chronic active hepatitis (CAH) have been evaluated in a randomized, double-blind, placebo-controlled study. Twenty-six patients with serum alanine aminotransferase (ALT) values at least twice the normal u